Dehydrogenase inhibitor, Ranolazine, Purity ≥98%

Synonym: 95635-55-5; Ranexa; N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide; CVT-303; RAN D; Ran4; N-(2,6-Dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide; Dehydrogenase inhibitor

MDL: MFCD00864690
CAS Number: 95635-55-5
Compound CID: 56959

Product Size

25 mg; 50 mg; 100 mg; 200 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Ranolazine, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting dehydrogenases. The molecular weight of the compound is 427.5, and its molecular formula is C₂₄H₃₃N₃O₄.

Molecular Weight

427.5

Molecular Formula

C₂₄H₃₃N₃O₄

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 77 mg/mL (180.1 mM); Water: insoluble; Ethanol: 18 mg/mL (42.09 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

Ranolazine can be studied extensively for its potential therapeutic applications in the treatment of cardiac conditions like heart failure, though its primary indication remains angina.